The first drug specifically developed to treat uncontrollable laughing or crying, or pseudobulbar affect, was approved by the U.S. Food and Drug Administration on October 29. Clinical trials showed that Nuedexta, which is taken orally, significantly reduced episodes in people with MS, ALS and other disorders.
Researchers convened in Sweden last month at the annual ECTRIMS (European Committee for Treatment and Research in MS) conference. Results were presented on emerging MS therapies, including Teriflunomide, an oral drug that inhibits specific immune cells. In addition, two presentations and 14 posters reported on ongoing CCSVI research.
This month marks the 10th anniversary of the National Family Caregiver Support program. The Society’s MS and Carepartners page includes a wealth of information and resources as well as tools and materials to help honor caregivers.
Meet people moving their lives forward with MS, get inspired by some of our volunteer leaders and more at the National MS Society’s National Conference. Streaming video of event highlights is now archived so everyone can join the movement.
This communication is partially sponsored through the generous support of Bayer HealthCare, Biogen Idec, Novartis Pharmaceuticals Corporation, and Teva Neuroscience, Inc.
MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS. JOIN THE MOVEMENT®
Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please visit our Web site.
Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.
National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017
This message was sent to . To ensure that you continue to receive our emails, please add us to your address book.